ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för cannabigerol. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

11 träffar

Bibliografisk träff 2020-01-13

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus.

di Giacomo V, Chiavaroli A, Orlando G, Cataldi A, Rapino M, Di Valerio V, Leone S, Brunetti L, Menghini L, Recinella L, Ferrante C.

Antioxidants (Basel) · research-article; journal article · DOI 10.3390/antiox9010071

Bibliografisk träff 2019-04-29

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Brierley DI, Harman JR, Giallourou N, Leishman E, Roashan AE, Mellows BAD, Bradshaw HB, Swann JR, Patel K, Whalley BJ, Williams CM.

J Cachexia Sarcopenia Muscle · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1002/jcsm.12426

Bibliografisk träff 2018-06-21

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes.

Navarro G, Varani K, Reyes-Resina I, Sánchez de Medina V, Rivas-Santisteban R, Sánchez-Carnerero Callado C, Vincenzi F, Casano S, Ferreiro-Vera C, Canela EI, Borea PA, Nadal X, Franco R.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2018.00632

Bibliografisk träff 2018-02-07

Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.

Smeriglio A, Giofrè SV, Galati EM, Monforte MT, Cicero N, D'Angelo V, Grassi G, Circosta C.

Fitoterapia · journal article · DOI 10.1016/j.fitote.2018.02.002

Bibliografisk träff 2017-04-03

Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ9-Tetrahydrocannabivarin, and Cannabigerol in Mouse Peripheral Tissues.

Piscitelli F, Pagano E, Lauritano A, Izzo AA, Di Marzo V.

Anal Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.analchem.7b01094

Bibliografisk träff 2016-08-09

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl) · research-article; journal article · DOI 10.1007/s00213-016-4397-4

Bibliografisk träff 2014-09-30

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.

Borrelli F, Pagano E, Romano B, Panzera S, Maiello F, Coppola D, De Petrocellis L, Buono L, Orlando P, Izzo AA.

Carcinogenesis · research support, non-u.s. gov't; journal article · DOI 10.1093/carcin/bgu205

Bibliografisk träff 2013-02-12

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.

Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Pagano E, Di Marzo V, Izzo AA.

Biochem Pharmacol · journal article · DOI 10.1016/j.bcp.2013.01.017

Bibliografisk träff 2011-09-08

Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).

Pollastro F, Taglialatela-Scafati O, Allarà M, Muñoz E, Di Marzo V, De Petrocellis L, Appendino G.

J Nat Prod · journal article · DOI 10.1021/np200500p

Bibliografisk träff 2010-06-01

Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.

Hidvégi E, Somogyi GP.

Pharmazie · journal article

Bibliografisk träff 1982-12-01

Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds.

Eisohly HN, Turner CE, Clark AM, Eisohly MA.

J Pharm Sci · journal article · DOI 10.1002/jps.2600711204

Gå till forskningen.

Publikationer i urvalet

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus.

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Cannabigerol Action at Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptors and at CB<sub>1</sub>-CB<sub>2</sub> Heteroreceptor Complexes.

Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.

Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ<sup>9</sup>-Tetrahydrocannabivarin, and Cannabigerol in Mouse Peripheral Tissues.

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.

Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).

Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.

Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds.